iBio, Inc.
Disclosed SEC business address
600 MADISON AVENUE, SUITE 1601, NEW YORK, NY, 10022-1737
iBio, Inc. (ticker IBIO, CIK 0001420720) is tracked by Global Barry from its public SEC filings and disclosures. Disclosed industry classification: Pharmaceutical Preparations (SIC 2834). Disclosed business address country: United States. Every item is grounded on the cited public source — no figures are fabricated.
Go deeper
This is the free public preview. Open the deeper, source-linked evidence detail and the full in-app workspace. You have 5 free company deep views left this month.
Sources
- U.S. Securities and Exchange Commission, EDGAR · XBRL company facts · retrieved 2026-10-24T23:45:33.566988+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing index · retrieved 2026-10-19T18:37:56.311091+00:00
- SEC EDGAR · issuer filing index
Grounded on public SEC filings and disclosures with explicit evidence tiers and citations. This page is informational only and is not investment advice. No figures are fabricated; unavailable data is shown as unavailable.